Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Sanara Medtech Inc

SMTI ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Small Cap Analyst: HOLD

Last Close

$34.73

▲ +0.03%

Market Cap $319.10M · Vol 241.26K

Key Metrics

P/E Ratio

N/A

FWD: 63.25

Market Cap

$319.10M

Small Cap

Div Yield

N/A

EPS Growth

+11.76%

YoY

RSI (14)

74.50

Momentum

Beta

1.20

vs Market

52W High

$35.85

3.12% below

52W Low

$16.05

116.39% above

Volume

241.26K

Avg 137.99K

P/B

35.18

Price-to-book

ROE

N/A

Return on equity

Free Float

52.03%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Sanara Medtech Inc (SMTI) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SMTI pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.46%

+1.97%

+57.01%

+72.87%

YTD

+48.74%

+2.03%

-4.85%

+0.32%

Financials & Valuation

TTM · Annual

Total Revenue	$103.12M
Net Income	$-393,120.00
Revenue Growth (YoY)	+8.93%
Gross Margin	90.13%
Operating Margin	9.12%
Net Profit Margin	-0.38%
ROE	N/A
ROA · ROIC	-0.49% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	63.25
PEG Ratio	N/A
P/S	1.95
P/B	35.18
P/FCF	94.20
EPS Growth	+11.76%
Outstanding Shares	9.19M

Technical Indicators

50-Day SMA	$30.07
200-Day SMA	$23.23
RSI (14)	74.50
Beta	1.20
52-Week High	$35.85
52-Week Low	$16.05

Volume Today	241.26K
Avg Daily Volume (30D)	137.99K
Relative Volume	1.75x
Volatility (10D)	6.41
Volatility (30D)	48.76
Free Float	52.03%

Analyst Consensus

HOLD

Current Price $34.73

Mean Target $35.00

52W Low$16.05 52W High$35.85

Current

Target

$16.05 $35.85

Current Analyst target

+0.78% upside potential · 3 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SKS528

ISINUS79957L1008

CountryUnited States of America

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 10, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -0.88% JNJ Johnson & Johnson -1.15% ABBV Abbvie Inc -1.44% NVS Novartis AG -1.90% NOVN.S Novartis AG -1.33%

Company Profile

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.